Xilio Therapeutics Statistics
NASDAQ: XLOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.01+0.01 (+0.11%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Xilio Therapeutics by the numbers
Xilio Therapeutics has a market capitalization of $59.3 million based on 6.58M shares outstanding. With trailing EPS of $-0.60, Xilio Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.7% below its 50-day average and 5.0% above its 200-day average.
Average daily trading volume is 20.06K shares, or about $180,705 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XLO valuation vs. peer median
| Metric | XLO | Peer median | Difference |
|---|---|---|---|
| Market cap | $59.29M | $59.77M | -1% |
| Avg. volume | 20.06K | 620.91K | -97% |
Peer median across 8 companies: CNTB, BOLD, ATHE, ACET, ALDX, PLRX, RNXT, MREO.
Valuation
- Market cap
- $59.29M
- EPS (TTM)
- $-0.60
- Shares outstanding
- 6.58M
Price and trading
- Previous close
- 9.00
- Open
- 9.01
- Day range
- 9.01 – 9.01
- 52-week range
- 6.47 – 12.59
- 52-week change
- -21.71%
- Beta
- —
- Volume
- 922
- Average volume
- 20.06K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2025
Additional statistics
- Market Cap
- 59.29M
- Forward Pe
- -15.53
- Eps
- -0.60
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.59
- Week52 Low
- 6.47
- Avg Volume
- 20,056.00
- Shares Outstanding
- 6.58M
- Ma50
- 9.07
- Ma200
- 8.58
- Earnings Date
- Aug 6, 2025
- Pct From52w High
- -28.41%
- Pct From52w Low
- 39.30%